Study Evaluating Two Dose Levels of Targretin Capsules in Participants With Refractory Cutaneous T-Cell Lymphoma (CTCL)
Clinical trial NCT01007448 · COMPLETED
Trial details
- NCT number
- NCT01007448
- Sponsor
- Bausch Health Americas, Inc.
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2010-01-06
- Primary completion
- 2014-02-20
- Enrollment
- 59
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.